Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Jordan SC"" wg kryterium: Wszystkie pola


Tytuł :
Outcomes at 3 years post-transplant in imlifidase-desensitized kidney transplant patients.
Autorzy :
Kjellman C; Hansa Biopharma AB, Lund, Sweden.
Maldonado AQ; Hansa Biopharma AB, Lund, Sweden.
Sjöholm K; Hansa Biopharma AB, Lund, Sweden.
Lonze BE; NYU Langone Transplant Institute, New York, New York, USA.
Montgomery RA; NYU Langone Transplant Institute, New York, New York, USA.
Runström A; Hansa Biopharma AB, Lund, Sweden.
Lorant T; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Desai NM; Johns Hopkins University, Baltimore, Maryland, USA.
Legendre C; Hôpital Necker & Paris Descartes University, Paris, France.
Lundgren T; Department of Transplantation Surgery, Karolinska Institutet, Stockholm, Sweden.
von Zur Mühlen B; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Vo AA; Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA.
Olsson H; Hansa Biopharma AB, Lund, Sweden.
Jordan SC; Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Jul 08. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
Autorzy :
Jordan SC; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Clinical and experimental immunology [Clin Exp Immunol] 2021 Jun; Vol. 204 (3), pp. 310-320. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
COVID-19/*immunology
COVID-19 Vaccines/*immunology
SARS-CoV-2/*physiology
T-Lymphocytes/*immunology
Adaptive Immunity ; Humans ; Immunity, Humoral ; Immunity, Innate ; Interleukin-6/metabolism ; Vaccine Potency
Czasopismo naukowe
Tytuł :
Infectious Complications in Tocilizumab-treated Kidney Transplant Recipients.
Autorzy :
Sethi S; Division of Nephrology, Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Peng A
Najjar R
Vo A
Jordan SC
Huang E
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Aug 01; Vol. 105 (8), pp. 1818-1824.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
Autorzy :
Jackson KR; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Long J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Motter J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Bowring MG; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Chen J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Waldram MM; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Orandi BJ; Department of Surgery, University of Alabama, Birmingham, AL.
Montgomery RA; The NYU Transplant Institute, New York University Langone Medical Center, New York, NY.
Stegall MD; Department of Surgery, Mayo Clinic, Rochester, MN.
Jordan SC; Department of Medicine, Cedars-Sinai Comprehensive Transplant Center, Los Angeles, CA.
Benedetti E; Department of Surgery, University of Illinois-Chicago, Chicago, IL.
Dunn TB; Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Ratner LE; Department of Surgery, Columbia University Medical Center, New York, NY.
Kapur S; Department of Surgery, New York Presbyterian/Weill Cornell Medical Center, New York, NY.
Pelletier RP; Department of Surgery, Robert Wood Johnson University Hospital, New Brunswick, NJ.
Roberts JP; Department of Surgery, University of California-San Francisco, San Francisco, CA.
Melcher ML; Department of Surgery, Stanford University, Palo Alto, CA.
Singh P; Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA.
Sudan DL; Department of Surgery, Duke University Medical Center, Durham, NC.
Posner MP; Department of Surgery, Virginia Commonwealth University, Richmond, VA.
El-Amm JM; Integris Baptist Medical Center, Transplant Division, Oklahoma City, OK.
Shapiro R; Recanti Miller Transplantation Institute, Mount Sinai Hospital, New York, NY.
Cooper M; Medstar Georgetown Transplant Institute, Washington, DC.
Verbesey JE; Medstar Georgetown Transplant Institute, Washington, DC.
Lipkowitz GS; Department of Surgery, Baystate Medical Center Springfield, MA.
Rees MA; Department of Urology, University of Toledo Medical Center, Toledo, OH.
Marsh CL; Department of Surgery, Scripps Clinic and Green Hospital, La Jolla, CA.
Sankari BR; Department of Urology, Cleveland Clinic, Cleveland, OH.
Gerber DA; Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, NC.
Wellen J; Department of Surgery, Barnes-Jewish Hospital, St. Louis, MO.
Bozorgzadeh A; Department of Surgery, University of Massachusetts Memorial Medical Center, Worcester, MA.
Gaber AO; Department of Surgery, Houston Methodist Hospital, Houston, TX.
Heher E; Department of Medicine, Massachusetts General Hospital, Boston, MA.
Weng FL; Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, Livingston, NJ.
Djamali A; Department of Medicine, University of Wisconsin, Madison, WI.
Helderman JH; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Concepcion BP; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Brayman KL; Department of Surgery, University of Virginia, Charlottesville, VA.
Oberholzer J; Department of Surgery, University of Virginia, Charlottesville, VA.
Kozlowski T; Department of Surgery, University of Florida, Gainesville, FL.
Covarrubias K; Department of Surgery, University of California San Diego, San Diego, CA.
Desai N; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.; Scientific Registry of Transplant Recipients, Minneapolis, MN.
Garonzik-Wang J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 436-442.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Healthcare Disparities*
Histocompatibility*
Kidney Transplantation*/adverse effects
Kidney Transplantation*/mortality
Living Donors*
Practice Patterns, Physicians'*
Graft Rejection/*prevention & control
Graft Survival/*drug effects
HLA Antigens/*immunology
Immunosuppressive Agents/*therapeutic use
Isoantibodies/*blood
Adult ; Female ; Graft Rejection/blood ; Graft Rejection/immunology ; Graft Rejection/mortality ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Quality Indicators, Health Care ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
Autorzy :
Puliyanda DP; Pediatric Nephrology Cedars Sinai Medical Center, Los Angeles, CA, USA.
Swinford R; Pediatric Nephrology, UTHealth, University of Texas at Houston, Houston, TX, USA.
Pizzo H; Pediatric Nephrology Cedars Sinai Medical Center, Los Angeles, CA, USA.
Garrison J; Pediatric Nephrology Cedars Sinai Medical Center, Los Angeles, CA, USA.
De Golovine AM; Pediatric Nephrology, UTHealth, University of Texas at Houston, Houston, TX, USA.
Jordan SC; Pediatric Nephrology Cedars Sinai Medical Center, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Pediatric transplantation [Pediatr Transplant] 2021 Mar; Vol. 25 (2), pp. e13850. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab.
Autorzy :
Jordan SC; Comprehensive Transplant Center, Transplant Immunotherapy Program Cedars-Sinai Medical Center, Los Angeles, California, USA.
Kucher K; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Bagger M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Hockey HU; Biometrics Matters Ltd., Hamilton, New Zealand.
Wagner K; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
Ammerman N; Comprehensive Transplant Center, Transplant Immunotherapy Program Cedars-Sinai Medical Center, Los Angeles, California, USA.
Vo A; Comprehensive Transplant Center, Transplant Immunotherapy Program Cedars-Sinai Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2020 Sep; Vol. 20 (9), pp. 2581-2588. Date of Electronic Publication: 2020 May 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Kidney Failure, Chronic*/surgery
Kidney Transplantation*
Organ Transplantation*
Antibodies, Monoclonal ; Humans ; Immunoglobulins, Intravenous
Czasopismo naukowe
Tytuł :
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes).
Autorzy :
Jordan SC; Cedars-Sinai Medical Center, Los Angeles, CA.
Legendre C; Hopital Necker & Paris Descartes University, Paris, France.
Desai NM; Johns Hopkins University, Baltimore, MD.
Lorant T; Uppsala University, Uppsala, Sweden.; Hansa Biopharma AB, Lund, Sweden.
Bengtsson M; Uppsala University, Uppsala, Sweden.
Lonze BE; NYU Langone Transplant Institute, New York, NY.
Vo AA; Cedars-Sinai Medical Center, Los Angeles, CA.
Runström A; Hansa Biopharma AB, Lund, Sweden.
Laxmyr L; Hansa Biopharma AB, Lund, Sweden.
Sjöholm K; Hansa Biopharma AB, Lund, Sweden.
Schiött Å; Hansa Biopharma AB, Lund, Sweden.
Sonesson E; Hansa Biopharma AB, Lund, Sweden.
Wood K; Hansa Biopharma AB, Lund, Sweden.
Winstedt L; Hansa Biopharma AB, Lund, Sweden.
Kjellman C; Hansa Biopharma AB, Lund, Sweden.
Montgomery RA; NYU Langone Transplant Institute, New York, NY.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Aug 01; Vol. 105 (8), pp. 1808-1817.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Reply to Olivera and Mallat.
Autorzy :
Jordan SC; Nephrology and Transplant Immunology, Cedars-Sinai Medical Center, Los Angeles, California.
Huang E; Nephrology and Transplant Immunology, Cedars-Sinai Medical Center, Los Angeles, California.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. e272-e273.
Typ publikacji :
Letter; Comment
Opinia redakcyjna
Tytuł :
Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort.
Autorzy :
Sawinski DL; Renal, Electrolyte, and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mehta S; Section of Transplant Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Alhamad T; Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Bromberg JS; Department of Surgery and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Fischbach B; Baylor University Medical Center, Dallas, Texas, USA.
Aeschbacher T; CareDx Inc., Brisbane, California, USA.
Ghosh S; CareDx Inc., Brisbane, California, USA.
Shekhtman G; CareDx Inc., Brisbane, California, USA.
Dholakia S; CareDx Inc., Brisbane, California, USA.
Brennan DC; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Poggio E; Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio, USA.
Bloom RD; Renal, Electrolyte, and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jordan SC; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.; Division of Nephrology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Clinical transplantation [Clin Transplant] 2021 Jun 28, pp. e14402. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro.
Autorzy :
Ge S; Transplant Immunology Laboratory, Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Chu M; Transplant Immunology Laboratory, Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Choi J; Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Louie S; Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Vo A; Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Jordan SC; Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Toyoda M; Transplant Immunology Laboratory, Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Aug; Vol. 104 (8), pp. 1574-1579.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody-Dependent Cell Cytotoxicity/*drug effects
Bacterial Proteins/*therapeutic use
Immunosuppressive Agents/*pharmacology
Killer Cells, Natural/*drug effects
Organ Transplantation/*adverse effects
Adult ; Antibody-Dependent Cell Cytotoxicity/immunology ; Bacterial Proteins/pharmacology ; Biological Assay ; Cells, Cultured ; Complement Activation/drug effects ; Desensitization, Immunologic/methods ; HLA Antigens/immunology ; Humans ; Immunosuppressive Agents/therapeutic use ; Interferon-gamma/immunology ; Interferon-gamma/metabolism ; Isoantibodies/immunology ; Isoantibodies/metabolism ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Leukocytes, Mononuclear ; Primary Cell Culture ; Receptors, IgG/immunology ; Receptors, IgG/metabolism ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł :
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection.
Autorzy :
Jordan SC; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Ammerman N; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Choi J; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Huang E; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Peng A; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Sethi S; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Najjar R; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Kim I; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Toyoda M; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Kumar S; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Lim K; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Vo A; Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2020 Jun; Vol. 20 Suppl 4, pp. 42-56.
Typ publikacji :
Journal Article
MeSH Terms :
Graft Rejection*/prevention & control
Kidney Transplantation*
Graft Survival ; Histocompatibility ; Humans ; Isoantibodies ; Plasmapheresis ; Rituximab
Czasopismo naukowe
Tytuł :
Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy.
Autorzy :
Chan CY; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Teo S; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Lu L; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Chan YH; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Lau PY; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Than M; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Jordan SC; Cedars Sinai Medical Center, Los Angeles, California.
Lam KP; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), Singapore; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Ng KH; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.
Yap HK; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore. Electronic address: .
Pokaż więcej
Źródło :
Translational research : the journal of laboratory and clinical medicine [Transl Res] 2021 Sep; Vol. 235, pp. 48-61. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation.
Autorzy :
Motter JD; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jackson KR; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Long JJ; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Waldram MM; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Orandi BJ; Department of Surgery, University of Alabama, Birmingham, Alabama, USA.
Montgomery RA; New York University Langone Medical Center, The NYU Transplant Institute, New York, New York, USA.
Stegall MD; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Jordan SC; Department of Medicine, Cedars-Sinai Comprehensive Transplant Center, Los Angeles, California, USA.
Benedetti E; Department of Surgery, University of Illinois-Chicago, Chicago, Illinois, USA.
Dunn TB; Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ratner LE; Department of Surgery, Columbia University Medical Center, New York, New York, USA.
Kapur S; Department of Surgery, New York Presbyterian/Weill Cornell Medical Center, New York, New York, USA.
Pelletier RP; Department of Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.
Roberts JP; Department of Surgery, University of California-San Francisco, San Francisco, California, USA.
Melcher ML; Department of Surgery, Stanford University, Palo Alto, California, USA.
Singh P; Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
Sudan DL; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Posner MP; Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA.
El-Amm JM; Integris Baptist Medical Center, Transplant Division, Oklahoma City, Oklahoma, USA.
Shapiro R; Recanati/Miller Transplantation Institute, Mount Sinai Hospital, New York, New York, USA.
Cooper M; Medstar Georgetown Transplant Institute, Washington, District of Columbia, USA.
Verbesey JE; Medstar Georgetown Transplant Institute, Washington, District of Columbia, USA.
Lipkowitz GS; Department of Surgery, Baystate Medical Center, Springfield, Massachusetts, USA.
Rees MA; Department of Urology, University of Toledo Medical Center, Toledo, Ohio, USA.
Marsh CL; Department of Surgery, Scripps Clinic and Green Hospital, La Jolla, California, USA.
Sankari BR; Department of Urology, Cleveland Clinic, Cleveland, Ohio, USA.
Gerber DA; Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Wellen JR; Department of Surgery, Barnes-Jewish Hospital, St. Louis, Missouri, USA.
Bozorgzadeh A; Department of Surgery, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, USA.
Gaber AO; Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA.
Heher EC; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Weng FL; Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, Livingston, New Jersey, USA.
Djamali A; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Helderman JH; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Concepcion BP; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Brayman KL; Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
Oberholzer J; Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
Kozlowski T; Department of Surgery, University of Florida, Gainesville, Florida, USA.
Covarrubias K; Department of Surgery, University of California San Diego, San Diego, California, USA.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.; Scientific Registry of Transplant Recipients, Minneapolis, Minnesota, USA.
Garonzik-Wang JM; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Apr; Vol. 21 (4), pp. 1612-1621. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Kidney Transplantation*/adverse effects
Delayed Graft Function/etiology ; Graft Rejection/etiology ; Graft Survival ; Humans ; Living Donors ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study.
Autorzy :
Huang E; Department of Medicine, Division of Nephrology, Transplant Immunology Laboratory, Transplant Immunotherapy Program, United States.
Isonaka S; Department of Clinical Transformation, Cedars-Sinai Medical Center, Los Angeles, California, United States.
Yang H; Department of Clinical Transformation, Cedars-Sinai Medical Center, Los Angeles, California, United States.
Salce E; Department of Clinical Transformation, Cedars-Sinai Medical Center, Los Angeles, California, United States.
Rosales E; Department of Clinical Transformation, Cedars-Sinai Medical Center, Los Angeles, California, United States.
Jordan SC; Department of Medicine, Division of Nephrology, Transplant Immunology Laboratory, Transplant Immunotherapy Program, United States. Electronic address: stan.jordan@cshs.org.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Apr; Vol. 105, pp. 245-251. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Critical Illness*
SARS-CoV-2*
Antibodies, Monoclonal, Humanized/*therapeutic use
COVID-19/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Respiration, Artificial ; Retrospective Studies
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.
Autorzy :
Phadke VK; Emory University Vaccine and Treatment Evaluation Unit (VTEU), Division of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, 500 Irvin Court, Suite 200, Decatur, GA 30030 USA.; The Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Emory University, Decatur, GA USA.
Scanlon N; The Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Emory University, Decatur, GA USA.
Jordan SC; Department of Medicine, Division of Nephrology, Transplant Immunology Laboratory, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, CA USA.
Rouphael NG; The Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Emory University, Decatur, GA USA.
Pokaż więcej
Źródło :
Current transplantation reports [Curr Transplant Rep] 2021 Mar 04, pp. 1-13. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.
Autorzy :
Schinstock CA; Mayo Clinic William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.
Mannon RB; Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL.
Budde K; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
Chong AS; Section of Transplantation, Department of Surgery, The University of Chicago, Chicago, IL.
Haas M; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Knechtle S; Duke Transplant Center, Department of Surgery, Duke University School of Medicine, Durham, NC.
Lefaucheur C; Université de Paris, Department of Transplantation, Saint Louis Hospital, Paris, France.
Montgomery RA; NYU Langone Transplant Institute, New York, NY.
Nickerson P; Transplant Immunology Laboratory, Shared Health and Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Tullius SG; Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Ahn C; Transplantation Center, Seoul National University Hospital, Seoul, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Askar M; Baylor University Medical Center, Transplant Immunology, Dallas, TX.
Crespo M; Department of Nephrology, Hospital del Mar and Institute Hospital del Mar for Medical Research, Barcelona, Spain.
Chadban SJ; Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia.
Feng S; Department of Surgery, University of California San Francisco, San Francisco, CA.
Jordan SC; Comprehensive Transplant Center, Cedars-Sinai Medical Center, West Hollywood, CA.
Man K; Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.
Mengel M; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Morris RE; Stanford University School of Medicine, Stanford, CA.
O'Doherty I; Critical Path Institute, Tucson, AZ.
Ozdemir BH; Department of Pathology, Baskent University, School of Medicine, Ankara, Turkey.
Seron D; Nephrology Department, Hospital Vall d'Hebron, Autonomous University of Barcelona, Catalonia, Spain.
Tambur AR; Comprehensive Transplant Center, Northwestern University, Chicago, IL.
Tanabe K; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Taupin JL; Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis APHP, Paris, France.; INSERM U976 Institut de Recherche Saint-Louis, Université Paris Diderot, Paris, France.
O'Connell PJ; Centre for Transplant and Renal Research, Westmead Institute of Medical Research, University of Sydney and Renal Unit, Westmead Hospital, NSW, Australia.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 May; Vol. 104 (5), pp. 911-922.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Consensus*
Kidney Transplantation*
Societies, Medical*
Antilymphocyte Serum/*therapeutic use
Graft Rejection/*therapy
Immunosuppression/*methods
Isoantibodies/*therapeutic use
Graft Rejection/immunology ; Humans ; Tissue Donors
Czasopismo naukowe
Tytuł :
Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection.
Autorzy :
Shin BH; Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA.
Everly MJ; Terasaki Research Institute, Los Angeles, CA.
Zhang H; Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA.
Choi J; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Vo A; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Zhang X; HLA and Immunogenetics Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA.
Huang E; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Jordan SC; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Toyoda M; Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Apr; Vol. 104 (4), pp. 856-863.
Typ publikacji :
Journal Article
MeSH Terms :
Histocompatibility*
Antibodies, Monoclonal, Humanized/*therapeutic use
Graft Rejection/*drug therapy
Graft Survival/*drug effects
HLA Antigens/*immunology
Immunoglobulins/*blood
Immunosuppressive Agents/*therapeutic use
Isoantibodies/*blood
Kidney Transplantation/*adverse effects
Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; B-Lymphocytes/drug effects ; B-Lymphocytes/immunology ; Chronic Disease ; Female ; Graft Rejection/diagnosis ; Graft Rejection/immunology ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Plasma Cells/drug effects ; Plasma Cells/immunology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics.
Autorzy :
Jordan SC; Comprehensive Transplant Center, Cedars-Sinai Medical Center 8900 Beverly Blvd. West Hollywood, CA.
Ammerman N
Vo A
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Jan; Vol. 104 (1), pp. 17-23.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Graft vs Host Disease*
Herpesvirus 4, Human*
Histocompatibility Antigens Class I ; Humans ; Immunoglobulin G ; Immunotherapy ; Infant, Newborn ; Killer Cells, Natural ; Receptors, Fc ; Transplantation, Haploidentical
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies